Deutsche Bank’s Akari Therapeutics AKTX Stock Holding History

Deutsche Bank’s Portfolio AKTX Stock Details AKTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-1	Closed	-$1K	–	4302
2019 Q4	$1K	Buy	+1	New	+$1.47K	﹤0.01%	4889
2019 Q3	–	Sell	-165	Closed	-$266K	–	4848
2019 Q2	$266K	Buy	165 +141	+588%	+$315K	﹤0.01%	3665
2019 Q1	$68K	Buy	+24	New	+$45.8K	﹤0.01%	4455
2018 Q1	–	Sell	-4	Closed	-$13K	–	5364
2017 Q4	$13K	Sell	4 -3	-43%	-$11.6K	﹤0.01%	4735
2017 Q3	$32K	Buy	7 +5	+250%	+$18.7K	﹤0.01%	4472
2017 Q2	$6K	Sell	2 -27	-93%	-$214K	﹤0.01%	4717
2017 Q1	$258K	Hold	29	–	–	﹤0.01%	3449
2016 Q4	$164K	Hold	29	–	–	﹤0.01%	3801
2016 Q3	$199K	Hold	29	–	–	﹤0.01%	3653
2016 Q2	$315K	Hold	29	–	–	﹤0.01%	3530
2016 Q1	$235K	Buy	29 +4	+16%	+$41.5K	﹤0.01%	3583
2015 Q4	$286K	Buy	+25	New	+$371K	﹤0.01%	3535

Other funds holding AKTX

Hikari Power Tokyo, Japan $855M AUM 14.24% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

OFW

Omnia Family Wealth Aventura, Florida $373M AUM 25.3% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

PCG

Private Capital Group West Hartford, Connecticut $133M AUM 11.23% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Deutsche Bank's AKTX Position: Q1 2020 in Review

Deutsche Bank sold out of Akari Therapeutics (AKTX) in Q1 2020, closing a stake of 1 share — an estimated $1K sold.

Deutsche Bank first reported a position in AKTX in Q4 2015 and held it in 12 quarters. The position peaked at $315K in Q2 2016. 12 funds tracked by Wall St. Rank hold AKTX as of Q1 2020.

Deutsche Bank reported no remaining Akari Therapeutics position as of Q1 2020 after selling out during the quarter.
Deutsche Bank sold 1 Akari Therapeutics share in Q1 2020, an estimated $1K.
Deutsche Bank first reported a position in Akari Therapeutics in Q4 2015 and held it in 12 quarters.
Deutsche Bank's Akari Therapeutics position peaked at $315K in Q2 2016.
12 funds tracked by Wall St. Rank held Akari Therapeutics as of Q1 2020.

Based on Deutsche Bank's 13F filing for Q1 2020, filed 14 May 2020.